aspect of
drug)
→
ReceivesAction
→
studied in 10 healthy subjects
| Typicality: | 0.344 |
| Saliency: | 0.220 |
| effect → be studied in → 10 healthy subjects | 7 |
| effect → be studied in → a group of healthy subjects | 4 |
| negative | neutral | positive |
| 0.028 | 0.918 | 0.054 |
| Raw frequency | 11 |
| Normalized frequency | 0.220 |
| Modifier score | 0.500 |
| Perplexity | 9.996 |